![](https://afos2025.com/wp-content/uploads/elementor/thumbs/Banner-06_0-qnzhmd2433kgr1vxgr85g7rpjzji5fxgxsrp3z9dnm.png)
Important dates to know:
- Deadline for abstract submission: 15 April 2025
- Notification of abstract acceptance: 15 May 2025
- Deadline for early bird registration: 31 May 2025
- Create an account: If you haven’t already, create an account on our submission portal to access the abstract submission form.
- Prepare your abstract: Write your abstract according to the provided guidelines, ensuring clarity, conciseness, and scientific rigor.
- Submit your abstract: Log in with your AFOS credentials to submit your application. Complete the online abstract application by the appropriate deadline.
- Review and confirmation: After submission, you will receive a confirmation email acknowledging receipt of your abstract. You will also be notified of the review outcome in due course.
- Abstract submissions are open to all professionals, including researchers, residents, fellows, and allied health professionals.
- Abstracts should be original research or clinical case reports that have not been previously published or presented at a major conference on or before April 15, 2025.
- Each abstract should adhere to the specified formatting guidelines and include essential components such as background, methods, results, and conclusions.
- Abstracts will undergo peer review by a panel of experts in the field of metabolic bone disease.
- Accepted abstracts will be scheduled for an oral, a poster, or an ePoster presentation at the AFOS 2025 meeting.
- Title
- The title is limited to 300 characters (including punctuation, but not spaces) and must begin with a capital letter and be followed by lowercase letters.
- Do not include any abbreviations in the title.
- Abstract:
- Length: Do not exceed the space provided on the application (300 words)
- Language: Use English only
- The abstract must include four parts:
- Background should clearly state the problem and the purpose of the study.
- Methods should provide a description of what was actually done.
- Results should contain the study findings.
- Discussion and conclusion should be based on the findings and relate to the stated purpose of the study and existing knowledge.
- DO NOT include an image, table, references, title, or author information in your abstract.
- DO NOT use abbreviations that have not been specified first.
- DO NOT include statements such as “the results will be discussed” or “data will be presented and discussed” in your conclusion, as these are NOT acceptable.
- List all authors in the space provided.